Brace is involved in the insurance market, focusing on new and niche risks, offering underwriting services and support to entrepreneurial partners. They have a multi-line approach and provide analytical insights to their partners.

Brace

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Metric
Company Name	Brace	Enovis Corporation
Symbol		ENOV
MSH ID	COM:BRACEUW	COM:ENOVIS
Market	PRIVATE	STOCKS
Sector	Financial Services & Finance	Industrials
Industry	Insurance	Industrial - Machinery
Country	GB	US
Stage	Series B
Employee Count		6.55K
Website	braceuw.com	enovis.com
LinkedIn
Founders

Metric
Market Cap		2.40B
Enterprise Value
Monthly Web Traffic	2.29K
Web Traffic Growth	-0.20
Valuation
Raised Capital	15.70M

Metric
Revenue		1.71B
Revenue (LTM)
Revenue (NTM)
Gross Profit		990.78M
EBITDA		194.39M
Operating Income		-65.71M
Net Income		-33.26M
EPS		-0.61
Diluted EPS		-0.61
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.58
Operating Profit Margin		-0.04
EBITDA Margin		0.11
Net Profit Margin		-0.02
Return on Equity		-0.01
Return on Assets		-0.01
Return on Capital Employed		-0.02

COM:BRACEUW

Brace

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-35.50
P/B Ratio		0.93
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.92
EV Multiple		50.02

Metric
Days Sales Outstanding		60.88
Days Payables Outstanding		64.95
Days Inventory Outstanding		280.07
Operating Cycle		356.60
Cash Conversion Cycle		282.17
Asset Turnover		0.38

Metric
Operating Cash Flow		134.99M
Free Cash Flow		12.77M
Cash Flow to Debt		0.25
Operating Cash Flow/Sales		0.08
Free Cash Flow Yield		-0.03

Metric
Cash & Equivalents		36.19M
Accounts Receivable		-16.32M
Inventory		468.83M
Goodwill		2.06B
Debt to Capitalization		0.30
Debt to Assets		0.11
Current Ratio		2.40
Quick Ratio		1.08

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue		0.04
SG&A to Revenue